Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - sumin+kang
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Modular Service Towers for Lunar and Mars Exploration
This technology involves the creation of modular service towers designed to support activities on the lunar and Martian surfaces. These towers are multi-functional, offering essential services such as lighting, power generation, and navigation. They also facilitate communication and computing for various lunar and Martian platforms, including robots,...
Published: 11/12/2024
|
Inventor(s):
Jekan Thangavelautham
,
Min Kang
Keywords(s):
Category(s):
Technology Classifications > Engineering & Physical Sciences > Aerospace Engineering
,
Technology Classifications > Engineering & Physical Sciences > Communications & Networking > Antenna
,
Technology Classifications > Engineering & Physical Sciences > Communications & Networking > Networking
,
Technology Classifications > Engineering & Physical Sciences > Communications & Networking > Optical
,
Technology Classifications > Engineering & Physical Sciences > Communications & Networking > Wireless
,
Technology Classifications > Engineering & Physical Sciences > Devices & Instrumentation > Robotics
,
Technology Classifications > Engineering & Physical Sciences > Transportation & Automotive > Telematics
Combination Therapy to Overcome Resistance to Platinum-Based Chemotherapy
Application MAST1 inhibitors to overcome resistance to platinum-based chemotherapy, exacerbated by dexamethasone co-administration. Key Benefits Co-administration of MAST1 inhibitor and MAST1-stabilizing protein inhibitor abrogates tumor resistance to cisplatin MAST1 inhibitor, lestaurtinib, has previously reached phase III clinical trials and...
Published: 7/30/2024
|
Inventor(s):
Sumin Kang
,
Jing Chen
Keywords(s):
Oncology
Category(s):
TechPub Algolia > Therapeutics
Cancer Cell Metabolism Inhibitors for Targeted Therapies
Application Glutamate dehydrogenase (GDH1) inhibitors targeting cancer cell metabolic pathways. Key Benefits Targets tricarboxylic acid (TCA) cycle/mitochondrial metabolism utilized by several cancer cell types for cell growth and survival. Reduces cell proliferation and viability in several tumor derived cell lines as well as in xenograft tumor...
Published: 7/30/2024
|
Inventor(s):
Sumin Kang
,
Jing Chen
,
Lingtao Jin
Keywords(s):
Oncology
,
Small Molecule
Category(s):
TechPub Algolia > Drug Discovery
,
TechPub Algolia > Therapeutics